(redirected from Human disease)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
References in periodicals archive ?
HemoShear Therapeutics is a biotechnology company with a transformational approach to understanding human disease biology driven byREVEAL-Tx(TM), our revolutionary discovery platform.
This collaboration helps us to further validate our technology, by enabling development of unique novel compounds with unique human disease models.
Under that rather broad umbrella, the institute will seek to encourage clinical research that emphasizes the use of environmental exposures to understand and better characterize common, complex diseases; develop improved models for human disease using our knowledge of environmental exposures and human biology; and enhance the role of the clinical investigator in environmental health sciences, bringing in both physicians and PhDs.
Trade in wildlife provides disease transmission mechanisms at levels that not only cause human disease outbreaks but also threaten livestock, international trade, rural livelihoods, native wildlife populations, and the health of ecosystems.
Using the zebrafish, DanioLabs has created a cost effective, high-throughput, in vivo model of IBD which has been shown to have clinical, pathological and biological relevance to the human disease.
In terms of human disease, biofilms tend to develop on inert surfaces (e.
When investigators identify the function and association of human genes with common chronic diseases, diagnosis, treatment, and classification of human diseases will be changed forever.
Since many diseases are caused by the inappropriate activity of specific genes, the ability to silence genes selectively through RNAi could provide a new way to treat a wide range of human diseases.
HemoShear is developing and applying human disease systems that provide a better way to predict how patients will react and respond to a drug candidate, improving its probability of success, resulting in safer, more effective therapies for patients, and potentially lowering drug development costs for the pharmaceutical industry.
In 2004, it caused widespread disease in poultry in Asia (4) and led to human disease in Thailand and Vietnam, with reported fatality rates of 66% and 80%, respectively (5,6).
Sometimes it's difficult to determine whether the animal model and human disease share an underlying mechanism.
The CIC bioGUNE is a nonprofit research and biotechnology business development hub created in Spain's Basque Country in 2005 to bring together the resources of state-of-the-art research, private industry and government to accelerate the search to identify, prevent and cure sources of human disease.

Full browser ?